AU4431400A - Anticancer agents containing ep1 antagonists as the active ingredient - Google Patents

Anticancer agents containing ep1 antagonists as the active ingredient

Info

Publication number
AU4431400A
AU4431400A AU44314/00A AU4431400A AU4431400A AU 4431400 A AU4431400 A AU 4431400A AU 44314/00 A AU44314/00 A AU 44314/00A AU 4431400 A AU4431400 A AU 4431400A AU 4431400 A AU4431400 A AU 4431400A
Authority
AU
Australia
Prior art keywords
antagonists
active ingredient
anticancer agents
agents containing
anticancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU44314/00A
Inventor
Takayuki Maruyama
Keiji Wakabayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ORGANIZATION FOR PHARMACEUTICAL SAFETY AND RESEARCH
Ono Pharmaceutical Co Ltd
National Cancer Center Japan
Original Assignee
JAPAN GOVERNMENT
ORGANIZATION FOR PHARMACEUTICA
Ono Pharmaceutical Co Ltd
National Cancer Center Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JAPAN GOVERNMENT, ORGANIZATION FOR PHARMACEUTICA, Ono Pharmaceutical Co Ltd, National Cancer Center Japan filed Critical JAPAN GOVERNMENT
Publication of AU4431400A publication Critical patent/AU4431400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
AU44314/00A 1999-05-12 2000-05-11 Anticancer agents containing ep1 antagonists as the active ingredient Abandoned AU4431400A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11/131195 1999-05-12
JP13119599 1999-05-12
PCT/JP2000/003028 WO2000069465A1 (en) 1999-05-12 2000-05-11 Anticancer agents containing ep1 antagonists as the active ingredient

Publications (1)

Publication Number Publication Date
AU4431400A true AU4431400A (en) 2000-12-05

Family

ID=15052259

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44314/00A Abandoned AU4431400A (en) 1999-05-12 2000-05-11 Anticancer agents containing ep1 antagonists as the active ingredient

Country Status (2)

Country Link
AU (1) AU4431400A (en)
WO (1) WO2000069465A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03008134A (en) * 2001-03-12 2004-03-10 Ono Pharmaceutical Co N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same.
SE0100873D0 (en) * 2001-03-13 2001-03-13 Astrazeneca Ab Method of treatment
KR20030081520A (en) * 2001-03-14 2003-10-17 오노 야꾸힝 고교 가부시키가이샤 Remedies for depression containing ep1 antagonist as the active ingredient
DE10121003A1 (en) 2001-04-28 2002-12-19 Aventis Pharma Gmbh Anthranilic acid amides, processes for their preparation, their use as medicaments and pharmaceutical preparations containing them
GB0114004D0 (en) 2001-06-08 2001-08-01 Glaxo Group Ltd Chemical compounds
GB0114005D0 (en) 2001-06-08 2001-08-01 Glaxo Group Ltd Chemical compounds
TW200817319A (en) 2006-08-10 2008-04-16 Astellas Pharma Inc Sulfonamide compound or salt thereof
WO2008099907A1 (en) 2007-02-16 2008-08-21 Ono Pharmaceutical Co., Ltd. Therapeutic agent for urinary excretion disorder
EP2305304A4 (en) 2008-04-28 2011-08-10 Nat University Corp Hamamatsu University School Of Medicine Immunopotentiating agent comprising ep1 agonist
WO2009157399A1 (en) 2008-06-23 2009-12-30 アステラス製薬株式会社 Sulfonamide compound or salt thereof
AU2009272033B2 (en) 2008-07-17 2011-10-13 Asahi Kasei Pharma Corporation Nitrogenated heterocyclic compound
CA2728098A1 (en) 2008-07-17 2010-01-21 Asahi Kasei Pharma Corporation Pyrazole-containing tricyclic compounds as_antagonits of an ep1 receptor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2107557T3 (en) * 1991-12-10 1997-12-01 Shionogi & Co DERIVATIVE OF HYDROXAMIC ACID BASED ON AROMATIC SULFONAMIDE.

Also Published As

Publication number Publication date
WO2000069465A1 (en) 2000-11-23

Similar Documents

Publication Publication Date Title
IL157940A0 (en) Drugs containing triazaspiro [5.5] undecane derivatives as the active ingredient
HK1043795A1 (en) Substituted bicyclic derivatives useful as anticancer agents.
AU2672501A (en) Medicament dispenser
AU2509901A (en) Medicament dispenser
AU1690399A (en) Neovascularization inhibitor containing dienogest as the active ingredient
AU3192700A (en) Medicinal compositions
AU6795600A (en) Gums containing antimicrobial agents
AU3556400A (en) Pharmaceutical compositions
AU1514401A (en) Medicament dispenser
AU2005300A (en) Medicinal compositions
AU2002309038A1 (en) Compositions for transmucosal administration containing coenzyme Q as the active ingredient
AU4431400A (en) Anticancer agents containing ep1 antagonists as the active ingredient
AU3078000A (en) Heterocyclic compounds and antitumor agents containing the same as the active ingredient
AU2001232238A1 (en) Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient
AU6460400A (en) Pharmaceutical compositions
AU4317500A (en) Antibiral compositions containing phorbol derivatives as the main active ingredient
AU5786300A (en) Muscarinic antagonists
AU6460200A (en) Pharmaceutical compositions
AU2023801A (en) Dihalopropenyloxybenzene derivatives and pesticides containing the same as the active ingredient
AU5809400A (en) Fungicidal compositions
AU9462498A (en) Hysteromyoma remedy containing dienogest as the active ingredient
AU6325200A (en) Stable biocidal compositions
AU6460300A (en) Pharmaceutical compositions
AU6460100A (en) Pharmaceutical compositions
AU1530601A (en) Biocide compositions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase